Roles of FGF receptors in mammalian development and congenital diseases.

Four fibroblast growth factor receptors (FGFR1-4) constitute a family of transmembrane tyrosine kinases that serve as high affinity receptors for at least 22 FGF ligands. Gene targeting in mice has yielded valuable insights into the functions of this important gene family in multiple biological processes. These include mesoderm induction and patterning; cell growth, migration, and differentiation; organ formation and maintenance; neuronal differentiation and survival; wound healing; and malignant transformation. Furthermore, discoveries that mutations in three of the four receptors result in more than a dozen human congenital diseases highlight the importance of these genes in skeletal development. In this review, we will discuss recent progress on the roles of FGF receptors in mammalian development and congenital diseases, with an emphasis on signal transduction pathways.

[1]  J. Rossant,et al.  Spatial and temporal patterns of ERK signaling during mouse embryogenesis , 2003, Development.

[2]  G. Guy,et al.  Tyrosine Phosphorylation of Sprouty2 Enhances Its Interaction with c-Cbl and Is Crucial for Its Function* , 2003, Journal of Biological Chemistry.

[3]  C. Deng,et al.  A Ser250Trp substitution in mouse fibroblast growth factor receptor 2 (Fgfr2) results in craniosynostosis , 2003 .

[4]  G. McVean,et al.  Evidence for Selective Advantage of Pathogenic FGFR2 Mutations in the Male Germ Line , 2003, Science.

[5]  E. Olson,et al.  Conditional inactivation of FGF receptor 2 reveals an essential role for FGF signaling in the regulation of osteoblast function and bone growth , 2003, Development.

[6]  C. Tickle,et al.  Negative Feedback Regulation of FGF Signaling Levels by Pyst1/MKP3 in Chick Embryos , 2003, Current Biology.

[7]  Nobuyuki Itoh,et al.  Preferential neurotrophic activity of fibroblast growth factor‐20 for dopaminergic neurons through fibroblast growth factor receptor‐1c , 2003, Journal of neuroscience research.

[8]  R. Nadeau,et al.  Sef Inhibits Fibroblast Growth Factor Signaling by Inhibiting FGFR1 Tyrosine Phosphorylation and Subsequent ERK Activation* , 2003, The Journal of Biological Chemistry.

[9]  Wolfgang Wurst,et al.  FGFR1 is independently required in both developing mid‐ and hindbrain for sustained response to isthmic signals , 2003, The EMBO journal.

[10]  Mary G. Lin,et al.  FGF signaling through FGFR1 is required for olfactory bulb morphogenesis , 2003, Development.

[11]  S. Tole,et al.  Fibroblast Growth Factor Receptor 3 Signaling Regulates the Onset of Oligodendrocyte Terminal Differentiation , 2003, The Journal of Neuroscience.

[12]  H. Ryoo,et al.  The Protein Kinase C Pathway Plays a Central Role in the Fibroblast Growth Factor-stimulated Expression and Transactivation Activity of Runx2* , 2003, The Journal of Biological Chemistry.

[13]  C. Deng,et al.  Mouse Models Orthologous to FGFR3-Related Skeletal Dysplasias , 2003, Pediatric pathology & molecular medicine.

[14]  W. Richardson,et al.  Fgfr3 expression by astrocytes and their precursors: evidence that astrocytes and oligodendrocytes originate in distinct neuroepithelial domains , 2003, Development.

[15]  J. Thiery,et al.  Novel fibroblast growth factor receptor 3 (FGFR3) mutations in bladder cancer previously identified in non-lethal skeletal disorders , 2002, European Journal of Human Genetics.

[16]  Fen Wang,et al.  Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice. , 2002, The American journal of pathology.

[17]  Kateryna Makova,et al.  Male-driven evolution. , 2002, Current opinion in genetics & development.

[18]  M. Bryckaert,et al.  Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway. , 2002, Blood.

[19]  R. Montironi,et al.  Frequent FGFR3 mutations in urothelial papilloma , 2002, The Journal of pathology.

[20]  G. Xiao,et al.  Fibroblast Growth Factor 2 Induction of the Osteocalcin Gene Requires MAPK Activity and Phosphorylation of the Osteoblast Transcription Factor, Cbfa1/Runx2* , 2002, The Journal of Biological Chemistry.

[21]  Andrea Vortkamp,et al.  Interaction of FGF, Ihh/Pthlh, and BMP signaling integrates chondrocyte proliferation and hypertrophic differentiation. , 2002, Developmental cell.

[22]  R. Bernards,et al.  Stable suppression of tumorigenicity by virus-mediated RNA interference. , 2002, Cancer cell.

[23]  Arndt Borkhardt,et al.  Blocking oncogenes in malignant cells by RNA interference--new hope for a highly specific cancer treatment? , 2002, Cancer cell.

[24]  M. Pines,et al.  The IIIc alternative of Fgfr2 is a positive regulator of bone formation. , 2002, Development.

[25]  S. Mcconnell,et al.  FGFR1 Is Required for the Development of the Auditory Sensory Epithelium , 2002, Neuron.

[26]  F. Pezzetti,et al.  Basic Fibroblast Growth Factor Autocrine Loop Controls Human Osteosarcoma Phenotyping and Differentiation , 2002, Molecular medicine.

[27]  N. Bazan,et al.  Phosphorylation of STAT-3 in Response to Basic Fibroblast Growth Factor Occurs through a Mechanism Involving Platelet-activating Factor, JAK-2, and Src in Human Umbilical Vein Endothelial Cells , 2002, The Journal of Biological Chemistry.

[28]  J. Pickles,et al.  Roles of Fibroblast Growth Factors in the Inner Ear , 2002, Audiology and Neurotology.

[29]  H. Höfler,et al.  Cancer progression and tumor cell motility are associated with the FGFR4 Arg(388) allele. , 2002, Cancer research.

[30]  C. Deng,et al.  Generation of Fgfr1 conditional knockout mice , 2002 .

[31]  C. Deng,et al.  Generation of Fgfr1 conditional knockout mice , 2002, Genesis.

[32]  J. Borg,et al.  8p12 Stem Cell Myeloproliferative Disorder: the FOP-Fibroblast Growth Factor Receptor 1 Fusion Protein of the t(6;8) Translocation Induces Cell Survival Mediated by Mitogen-Activated Protein Kinase and Phosphatidylinositol 3-Kinase/Akt/mTOR Pathways , 2001, Molecular and Cellular Biology.

[33]  Y. Eto,et al.  The incidence of thanatophoric dysplasia mutations in FGFR3 gene is higher in low‐grade or superficial bladder carcinomas , 2001, Cancer.

[34]  C. Deng,et al.  Fibroblast growth factor receptor 2 (Fgfr2) plays an important role in eyelid and skin formation and patterning , 2001, Developmental dynamics : an official publication of the American Association of Anatomists.

[35]  W. Imagawa,et al.  In vivo inhibition of keratinocyte growth factor receptor expression by estrogen and antagonism by progesterone in the mouse mammary gland. , 2001, The Journal of endocrinology.

[36]  E. Rubel,et al.  FGFR3 expression during development and regeneration of the chick inner ear sensory epithelia. , 2001, Developmental biology.

[37]  C. Tickle,et al.  Vertebrate limb development--the early stages in chick and mouse. , 2001, Current opinion in genetics & development.

[38]  J. Rossant,et al.  FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. , 2001, Developmental cell.

[39]  M. Murphy,et al.  Fibroblast Growth Factors In The Developing Central Nervous System , 2001, Clinical and experimental pharmacology & physiology.

[40]  J. Watson,et al.  Identification of a new fibroblast growth factor receptor, FGFR5. , 2001, Gene.

[41]  D. Levy,et al.  STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. , 2001, Development.

[42]  C. Deng,et al.  Highly activated Fgfr3 with the K644M mutation causes prolonged survival in severe dwarf mice. , 2001, Human molecular genetics.

[43]  I. Lax,et al.  Stimulation of phosphatidylinositol 3-kinase by fibroblast growth factor receptors is mediated by coordinated recruitment of multiple docking proteins , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Xiaofeng Li,et al.  Fibroblast Growth Factor Signaling and Basement Membrane Assembly Are Connected during Epithelial Morphogenesis of the Embryoid Body , 2001, The Journal of cell biology.

[45]  J. Pickles.  The expression of fibroblast growth factors and their receptors in the embryonic and neonatal mouse inner ear , 2001, Hearing Research.

[46]  K. Cailliau,et al.  Transduction cascades initiated by fibroblast growth factor 1 on Xenopus oocytes expressing MDA-MB-231 mRNAs. Role of Grb2, phosphatidylinositol 3-kinase, Src tyrosine kinase, and phospholipase Cgamma. , 2001, Cellular signalling.

[47]  J. G. Park,et al.  Mutations in fibroblast growth factor receptor 2 and fibroblast growth factor receptor 3 genes associated with human gastric and colorectal cancers. , 2001, Cancer research.

[48]  M. Goldfarb,et al.  Multiple Effector Domains within SNT1 Coordinate ERK Activation and Neuronal Differentiation of PC12 Cells* , 2001, The Journal of Biological Chemistry.

[49]  S C Robertson,et al.  Identification of tyrosine residues in constitutively activated fibroblast growth factor receptor 3 involved in mitogenesis, Stat activation, and phosphatidylinositol 3-kinase activation. , 2001, Molecular biology of the cell.

[50]  P. Maher,et al.  Importin β–Mediated Nuclear Import of Fibroblast Growth Factor Receptor , 2001, The Journal of Cell Biology.

[51]  G. Koh,et al.  A novel fibroblast growth factor receptor-5 preferentially expressed in the pancreas(1). , 2001, Biochimica et biophysica acta.

[52]  Nobuyuki Itoh,et al.  Fibroblast growth factors , 2001, Genome Biology.

[53]  C. Deng,et al.  A Ser(365)-->Cys mutation of fibroblast growth factor receptor 3 in mouse downregulates Ihh/PTHrP signals and causes severe achondroplasia. , 2001, Human molecular genetics.

[54]  B. Spencer‐Dene,et al.  Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. , 2001, Developmental biology.

[55]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[56]  P. Maher,et al.  Novel nuclear signaling pathway mediates activation of fibroblast growth factor-2 gene by type 1 and type 2 angiotensin II receptors. , 2001, Molecular biology of the cell.

[57]  G. Waksman,et al.  Loss of fibroblast growth factor receptor 2 ligand-binding specificity in Apert syndrome. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[58]  D. Birnbaum,et al.  FGFR1 et MOZ, deux gènes clés dans les hémopathies malignes associées à des réarrangements de la région chromosomique 8p11-12 , 2000 .

[59]  J. McCarthy,et al.  Syndromes involving craniosynostosis and midface hypoplasia. , 2000, Otolaryngologic clinics of North America.

[60]  R. Grainger,et al.  Expression of activated MAP kinase in Xenopus laevis embryos: evaluating the roles of FGF and other signaling pathways in early induction and patterning. , 2000, Developmental biology.

[61]  Eric Arnaud,et al.  Management of craniosynostoses , 2000, Child's Nervous System.

[62]  K. Cailliau,et al.  Signal transduction pathways triggered by fibroblast growth factor receptor 1 expressed in Xenopus laevis oocytes after fibroblast growth factor 1 addition , 2000 .

[63]  J. Crow.  The origins, patterns and implications of human spontaneous mutation , 2000, Nature Reviews Genetics.

[64]  J. Schlessinger,et al.  Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization. , 2000, Molecular cell.

[65]  B. Spencer‐Dene,et al.  FGF/FGFR-2(IIIb) Signaling Is Essential for Inner Ear Morphogenesis , 2000, The Journal of Neuroscience.

[66]  C. Deng,et al.  A Pro250Arg substitution in mouse Fgfr1 causes increased expression of Cbfa1 and premature fusion of calvarial sutures. , 2000, Human molecular genetics.

[67]  V. P. Eswarakumar,et al.  Fibroblast growth factor (FGF) signaling through PI 3-kinase and Akt/PKB is required for embryoid body differentiation , 2000, Oncogene.

[68]  J. G. Park,et al.  Novel transcripts of fibroblast growth factor receptor 3 reveal aberrant splicing and activation of cryptic splice sequences in colorectal cancer. , 2000, Cancer research.

[69]  A. N. Meyer,et al.  Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4 , 2000, Oncogene.

[70]  C. Deng,et al.  A neonatal lethal mutation in FGFR3 uncouples proliferation and differentiation of growth plate chondrocytes in embryos. , 2000, Human molecular genetics.

[71]  C. Deng,et al.  Elevated Cholesterol Metabolism and Bile Acid Synthesis in Mice Lacking Membrane Tyrosine Kinase Receptor FGFR4* , 2000, The Journal of Biological Chemistry.

[72]  Joseph Schlessinger,et al.  Crystal Structures of Two FGF-FGFR Complexes Reveal the Determinants of Ligand-Receptor Specificity , 2000, Cell.

[73]  T. Pawson,et al.  The SH2 tyrosine phosphatase Shp2 is required for mammalian limb development , 2000, Nature Genetics.

[74]  V. Fantl,et al.  Mammary gland oncogenes as indicators of pathways important in mammary gland development , 2000, Oncogene.

[75]  B. Spencer‐Dene,et al.  An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. , 2000, Development.

[76]  E. Jabs,et al.  The pleiotropic effects of fibroblast growth factor receptors in mammalian development. , 2000, Cell structure and function.

[77]  D. Ornitz,et al.  FGFs, heparan sulfate and FGFRs: complex interactions essential for development. , 2000, BioEssays : news and reviews in molecular, cellular and developmental biology.

[78]  R. Adar,et al.  The Transmembrane Mutation G380R in Fibroblast Growth Factor Receptor 3 Uncouples Ligand-Mediated Receptor Activation from Down-Regulation , 2000, Molecular and Cellular Biology.

[79]  W. Hendrickson,et al.  Structural interactions of fibroblast growth factor receptor with its ligands. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[80]  A. Wilkie,et al.  Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. , 1999, Development.

[81]  C. Deng,et al.  Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis. , 1999, The Journal of clinical investigation.

[82]  X. Zhan,et al.  Src is required for cell migration and shape changes induced by fibroblast growth factor 1 , 1999, Oncogene.

[83]  A. Yayon,et al.  Skeletal Dysplasia and Defective Chondrocyte Differentiation by Targeted Overexpression of Fibroblast Growth Factor 9 in Transgenic Mice , 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[84]  D. Smedley,et al.  ZNF198-FGFR1 transforms Ba/F3 cells to growth factor independence and results in high level tyrosine phosphorylation of STATS 1 and 5. , 1999, Neoplasia.

[85]  M. Muenke,et al.  Craniosynostosis syndromes: from genes to premature fusion of skull bones. , 1999, Molecular genetics and metabolism.

[86]  D. Chopin,et al.  Frequent activating mutations of FGFR3 in human bladder and cervix carcinomas , 1999, Nature Genetics.

[87]  A. McMahon,et al.  Indian hedgehog signaling regulates proliferation and differentiation of chondrocytes and is essential for bone formation. , 1999, Genes & development.

[88]  E. Jabs,et al.  Ocular anterior chamber dysgenesis in craniosynostosis syndromes with a fibroblast growth factor receptor 2 mutation. , 1999, American journal of medical genetics.

[89]  M. Bamshad,et al.  Severe achondroplasia with developmental delay and acanthosis nigricans (SADDAN): phenotypic analysis of a new skeletal dysplasia caused by a Lys650Met mutation in fibroblast growth factor receptor 3. , 1999, American journal of medical genetics.

[90]  D. Levy,et al.  FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. , 1999, Genes & development.

[91]  K. Sobue,et al.  Changes in the Balance of Phosphoinositide 3-Kinase/Protein Kinase B (Akt) and the Mitogen-activated Protein Kinases (ERK/p38MAPK) Determine a Phenotype of Visceral and Vascular Smooth Muscle Cells , 1999, The Journal of cell biology.

[92]  M. Momoi,et al.  bFGF inhibits the activation of caspase-3 and apoptosis of P19 embryonal carcinoma cells during neuronal differentiation , 1999, Cell Death and Differentiation.

[93]  Katsu Takahashi,et al.  Murine fibroblast growth factor receptor 1alpha isoforms mediate node regression and are essential for posterior mesoderm development. , 1999, Developmental biology.

[94]  D. Givol,et al.  A mouse model for achondroplasia produced by targeting fibroblast growth factor receptor 3. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[95]  C. Deng,et al.  Fibroblast growth factor receptors (FGFRs) and their roles in limb development , 1999, Cell and Tissue Research.

[96]  D. Donoghue,et al.  A novel skeletal dysplasia with developmental delay and acanthosis nigricans is caused by a Lys650Met mutation in the fibroblast growth factor receptor 3 gene. , 1999, American journal of human genetics.

[97]  R. Coombes,et al.  Increased expression of fibroblast growth factor 8 in human breast cancer , 1999, Oncogene.

[98]  J. Pickles,et al.  Fibroblast growth factor receptor expression in outer hair cells of rat cochlea. , 1998, Neuroreport.

[99]  D. Ornitz,et al.  Repression of hedgehog signaling and BMP4 expression in growth plate cartilage by fibroblast growth factor receptor 3. , 1998, Development.

[100]  T. Oka,et al.  In vivo and in vitro evidence of basic fibroblast growth factor action in mouse mammary gland development , 1998, FEBS letters.

[101]  M. Ko,et al.  Fibroblast growth factor 2 uses PLC-gamma1 for cell proliferation and PI3-kinase for alteration of cell shape and cell proliferation in corneal endothelial cells. , 1998, Molecular vision.

[102]  R. Einspanier,et al.  Expression and localization of members of the fibroblast growth factor family in the bovine mammary gland. , 1998, Journal of Dairy Science.

[103]  C. Deng,et al.  FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. , 1998, Development.

[104]  J. Heath,et al.  Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. , 1998, Human molecular genetics.

[105]  J. Rossant,et al.  Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. , 1998, Genes & development.

[106]  M. Goldfarb,et al.  Novel Recognition Motif on Fibroblast Growth Factor Receptor Mediates Direct Association and Activation of SNT Adapter Proteins* , 1998, The Journal of Biological Chemistry.

[107]  G. Martin,et al.  The roles of FGFs in the early development of vertebrate limbs. , 1998, Genes & development.

[108]  M. Evans,et al.  Crouzon‐like craniofacial dysmorphology in the mouse is caused by an insertional mutation at the Fgf3/Fgf4 locus , 1998, Developmental dynamics : an official publication of the American Association of Anatomists.

[109]  B. Hogan,et al.  Comparison of the expression of three highly related genes, Fgf8, Fgf17 and Fgf18, in the mouse embryo , 1998, Mechanisms of Development.

[110]  J. Heath,et al.  Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[111]  P. Leder,et al.  Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. , 1998, Development.

[112]  M. Rocchi,et al.  A novel chromosomal translocation t(4; 14)(p16.3; q32) in multiple myeloma involves the fibroblast growth-factor receptor 3 gene. , 1997, Blood.

[113]  J. Bresnick,et al.  A Role for Fibroblast Growth Factor Signaling in the Lobuloalveolar Development of the Mammary Gland , 1997, Journal of Mammary Gland Biology and Neoplasia.

[114]  J. Rossant,et al.  Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. , 1997, Development.

[115]  E. Schröck,et al.  Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3 , 1997, Nature Genetics.

[116]  G. Stamp,et al.  Fibroblast growth factor receptor signalling has a role in lobuloalveolar development of the mammary gland. , 1997, Journal of cell science.

[117]  M. Owen,et al.  Mutations Involving the Transcription Factor CBFA1 Cause Cleidocranial Dysplasia , 1997, Cell.

[118]  G. Karsenty,et al.  Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation , 1997, Cell.

[119]  D. Bar-Sagi,et al.  A Lipid-Anchored Grb2-Binding Protein That Links FGF-Receptor Activation to the Ras/MAPK Signaling Pathway , 1997, Cell.

[120]  S. Coons,et al.  Nuclear accumulation of fibroblast growth factor receptors in human glial cells-association with cell proliferation , 1997, Oncogene.

[121]  P. Leder,et al.  Fibroblast growth factor receptor-1 (FGFR-1) is essential for normal neural tube and limb development. , 1997, Developmental biology.

[122]  Xin-Yuan Fu,et al.  Activation of Statl by mutant fibroblast growth-factor receptor in thanatophoric dysplasia type II dwarfism , 1997, Nature.

[123]  M. Goldfarb,et al.  Functions of fibroblast growth factors in vertebrate development. , 1996, Cytokine & growth factor reviews.

[124]  A. Munnich,et al.  Common mutations in the gene encoding fibroblast growth factor receptor 3 account for achondroplasia, hypochondroplasia and thanatophoric dysplasia , 1996, Acta paediatrica (Oslo, Norway : 1992). Supplement.

[125]  J. Weissenbach,et al.  Clinical and genetic heterogeneity of hypochondroplasia. , 1996, Journal of medical genetics.

[126]  Clifford J. Tabin,et al.  Regulation of Rate of Cartilage Differentiation by Indian Hedgehog and PTH-Related Protein , 1996, Science.

[127]  B. Lanske,et al.  PTH/PTHrP Receptor in Early Development and Indian Hedgehog--Regulated Bone Growth , 1996, Science.

[128]  P. Maher,et al.  Nuclear accumulation of fibroblast growth factor receptors is regulated by multiple signals in adrenal medullary cells. , 1996, Molecular biology of the cell.

[129]  P. Maher.  Nuclear Translocation of fibroblast growth factor (FGF) receptors in response to FGF-2 , 1996, The Journal of cell biology.

[130]  V. Yong,et al.  Astrocytes promote process outgrowth by adult human oligodendrocytes in vitro through interaction between bFGF and astrocyte extracellular matrix , 1996, Glia.

[131]  D. Ornitz,et al.  Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia , 1996, Nature Genetics.

[132]  P. Maher,et al.  Nuclear localization of functional FGF receptor 1 in human astrocytes suggests a novel mechanism for growth factor action. , 1996, Brain research. Molecular brain research.

[133]  A. Munnich,et al.  Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). , 1996, Human molecular genetics.

[134]  Madhur Kumar,et al.  Developmental and FGF-2-Mediated Regulation of Syndecans (1–4) and Glypican in Oligodendrocytes , 1996, Molecular and Cellular Neuroscience.

[135]  Madhur Kumar,et al.  Regulation of FGF Receptors in the Oligodendrocyte Lineage , 1996, Molecular and Cellular Neuroscience.

[136]  Gary W. Harding,et al.  Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 , 1996, Nature Genetics.

[137]  P. Leder,et al.  Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone Growth , 1996, Cell.

[138]  D. Shi,et al.  A truncated FGF receptor blocks neural induction by endogenous Xenopus inducers. , 1996, Development.

[139]  A. Rapak,et al.  Translocation to Cytosol of Exogenous, CAAX-tagged Acidic Fibroblast Growth Factor (*) , 1995, The Journal of Biological Chemistry.

[140]  G. Dorn,et al.  Abnormal bone growth and selective translational regulation in basic fibroblast growth factor (FGF-2) transgenic mice. , 1995, Molecular biology of the cell.

[141]  A. Munnich,et al.  Stop codon FGFR3 mutations in thanatophoric dwarfism type 1 , 1995, Nature Genetics.

[142]  H. Bucher,et al.  A glycine 375-to-cysteine substitution in the transmembrane domain of the fibroblast growth factor receptor-3 in a newborn with achondroplasia , 1995, European Journal of Pediatrics.

[143]  D. Rimoin,et al.  Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3 , 1995, Nature Genetics.

[144]  B. Margolis,et al.  A region in Shc distinct from the SH2 domain can bind tyrosine-phosphorylated growth factor receptors. , 1994, The Journal of biological chemistry.

[145]  J. Rossant,et al.  fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. , 1994, Genes & development.

[146]  P. Leder,et al.  Murine FGFR-1 is required for early postimplantation growth and axial organization. , 1994, Genes & development.

[147]  Arnold Munnich,et al.  Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia , 1994, Nature.

[148]  D. Church,et al.  Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia , 1994, Cell.

[149]  Kirsten Sandvig,et al.  Dual mode of signal transduction by externally added acidic fibroblast growth factor , 1994, Cell.

[150]  D. Givol,et al.  Developmental localization of the splicing alternatives of fibroblast growth factor receptor-2 (FGFR2). , 1993, Developmental biology.

[151]  S. Werner,et al.  Targeted expression of a dominant‐negative FGF receptor mutant in the epidermis of transgenic mice reveals a role of FGF in keratinocyte organization and differentiation. , 1993, The EMBO journal.

[152]  G. Martin,et al.  Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. , 1992, Development.

[153]  S. Werner,et al.  Differential splicing in the extracellular region of fibroblast growth factor receptor 1 generates receptor variants with different ligand-binding specificities , 1992, Molecular and cellular biology.

[154]  Y. Yarden,et al.  Developmental expression of two murine fibroblast growth factor receptors, flg and bek. , 1991, Development.

[155]  M. Jaye,et al.  A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1 , 1991, Molecular and cellular biology.

[156]  B. Matthews,et al.  Three-dimensional structure of human basic fibroblast growth factor. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[157]  C. Damais,et al.  Activation of human dermal fibroblasts by fibroblast growth factors (FGFs) and/or interleukin-1 beta (IL-1 beta). , 1991, Lymphokine and cytokine research.

[158]  M. Kan,et al.  Fibroblast growth factor receptors from liver vary in three structural domains. , 1991, Science.

[159]  D. Johnson,et al.  Diverse forms of a receptor for acidic and basic fibroblast growth factors , 1990, Molecular and cellular biology.

[160]  Joseph Schlessinger,et al.  Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.

[161]  V. Fried,et al.  Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. , 1989, Science.

[162]  C. Stoll,et al.  Birth prevalence rates of skeletal dysplasias , 1989, Clinical genetics.

[163]  H. Ristow,et al.  Basic fibroblast growth factor and insulin‐like growth factor I are strong mitogens for cultured mouse keratinocytes , 1988, Journal of cellular physiology.

[164]  J. Annegers,et al.  Mortality in achondroplasia. , 1987, American journal of human genetics.

[165]  B. Olwin,et al.  Identification of the fibroblast growth factor receptor of Swiss 3T3 cells and mouse skeletal muscle myoblasts. , 1986, Biochemistry.

[166]  D. Danks,et al.  Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine. , 1979, Journal of medical genetics.

[167]  D. Gospodarowicz.  Localisation of a fibroblast growth factor and its effect alone and with hydrocortisone on 3T3 cell growth , 1974, Nature.

[168]  V. McKusick,et al.  Observations Suggesting Allelism of the Achondroplasia and Hypochondroplasia Genes , 1973, Journal of medical genetics.

[169]  A. Suhardja,et al.  Role of growth factors and their receptors in proliferation of microvascular endothelial cells , 2003, Microscopy research and technique.

[170]  L. Niswander.  Interplay between the molecular signals that control vertebrate limb development. , 2002, The International journal of developmental biology.

[171]  J. Thiery,et al.  Role of FGF10/FGFR2b signaling during mammary gland development in the mouse embryo. , 2002, Development.

[172]  Juan Carlos Izpisúa Belmonte,et al.  Patterning mechanisms controlling vertebrate limb development. , 2001, Annual review of cell and developmental biology.

[173]  P. Maher,et al.  Importin beta-mediated nuclear import of fibroblast growth factor receptor: role in cell proliferation. , 2001, The Journal of cell biology.

[174]  D. Birnbaum,et al.  [FGFR1 and MOZ, two key genes involved in malignant hemopathies linked to rearrangements within the chromosomal region 8p11-12]. , 2000, Bulletin du cancer.

[175]  I. Mason,et al.  Expression of FGFR1, FGFR2 and FGFR3 during early neural development in the chick embryo , 2000, Mechanisms of Development.

[176]  C. Irving,et al.  Regulation and function of FGF8 in patterning of midbrain and anterior hindbrain. , 2000, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[177]  C. Deng,et al.  A Lys644Glu substitution in fibroblast growth factor receptor 3 (FGFR3) causes dwarfism in mice by activation of STATs and ink4 cell cycle inhibitors. , 1999, Human molecular genetics.

[178]  E. Jabs,et al.  Clinical spectrum of fibroblast growth factor receptor mutations , 1999, Human mutation.

[179]  François Coulier,et al.  Of Worms and Men: An Evolutionary Perspective on the Fibroblast Growth Factor (FGF) and FGF Receptor Families , 1997, Journal of Molecular Evolution.

[180]  A. Munnich,et al.  Association de l'achondroplasie à une mutation dans le domaine transmembranaire du récepteur 3 des facteurs de croissance fibroblastiques (FGFR3) , 1996 .

[181]  A. Munnich,et al.  Mutations of the fibroblast growth factor receptor-3 gene in achondroplasia. , 1996, Hormone research.

[182]  A. Munnich,et al.  [Mutations of FGFR3 gene cause 3 types of nanisms with variably severity: achondroplasia, thanatophoric nanism and hypochondroplasia]. , 1996, Annales d'endocrinologie.

[183]  A. Munnich,et al.  [Association of achondroplasia to a mutation in the transmembrane domain of fibroblastic growth factor receptor 3 (FGFR3)]. , 1996, Annales d'Endocrinologie.

[184]  S. Werner,et al.  Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. , 1992, Development.